An increasing dose of omeprazole combined with amoxycillin cures Helicobacter pylori infection more effectively

被引:58
作者
Miehlke, S
Mannes, GA
Lehn, N
Hele, C
Stolte, M
Bayerdorffer, E
机构
[1] KRANKENHAUS BARMHERZIGEN BRUDER, DEPT INTERNAL MED, MUNICH, GERMANY
[2] TECH UNIV MUNICH, KLINIKUM RECHTS ISAR, DEPT MICROBIOL, D-8000 MUNICH, GERMANY
[3] KLINIKUM BAYREUTH, DEPT PATHOL, BAYREUTH, GERMANY
关键词
D O I
10.1046/j.1365-2036.1997.140316000.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The combination of omeprazole and amoxycillin has demonstrated effectiveness with very few side-effects in the treatment of H. pylori infection, however cure rates have varied widely. The present study addresses the question as to the extent to which the cure rate of H. pylori infection depends on the size of the daily omeprazole dose, and investigates other patient-related factors that influence treatment success. Methods: In a randomized, controlled and investigator-blinded trial, 163 hospitalized patients with H. pylori-associated gastritis were treated with 20 mg omeprazole once daily in the morning, 20 mg omeprazole b.d., 40 mg omeprazole b.d. or 60 mg omeprazole b.d. for 14 days. In addition, all patients received 1000 mg amoxycillin b.d. on days 5-14, Endoscopic and histological examinations were performed prior to treatment, at the end of treatment and 4 weeks after completion of treatment. Results: H. pylori infection was cured in 18 of 40 (45%, 95% CI: 29-62%), in 22 of 39 (56.4%, 95% CI: 40-72%), in 25 of 38 (65.8%, 95% CI: 49-80%), and in 33 of 40 (82.5%, 95% CI: 67-93%) patients, respectively, (P < 0.001). Side-effects leading to discontinuation of treatment occurred in only 1.2%. Conclusion: The daily dose of omeprazole is an important factor for the success of dual therapy comprising omeprazole and amoxycillin in curing H. pylori infection, Cure of H. pylori infection correlates positively and significantly with the size of the daily omeprazole dose, The combination of high-dose omeprazole and amoxycillin is an effective and well-tolerated regimen for the treatment of H. pylori-associated diseases.
引用
收藏
页码:323 / 329
页数:7
相关论文
共 43 条
[1]  
ANDREWS GR, 1967, AUSTRALAS ANN MED, V16, P230
[2]   THE ROLE OF ACID INHIBITION IN THE TREATMENT OF HELICOBACTER-PYLORI INFECTION [J].
AXON, ATR .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1994, 29 :16-23
[3]  
BANK S, 1995, GASTROENTEROLOGY, V108, pA52, DOI 10.1016/0016-5085(95)22870-5
[4]   REGRESSION OF PRIMARY GASTRIC LYMPHOMA OF MUCOSA-ASSOCIATED LYMPHOID-TISSUE TYPE AFTER CURE OF HELICOBACTER-PYLORI INFECTION [J].
BAYERDORFFER, E ;
NEUBAUER, A ;
RUDOLPH, B ;
THIEDE, C ;
LEHN, N ;
EIDT, S ;
STOLTE, M .
LANCET, 1995, 345 (8965) :1591-1594
[5]   DIFFERENCE IN EXPRESSION OF HELICOBACTER-PYLORI GASTRITIS IN ANTRUM AND BODY [J].
BAYERDORFFER, E ;
LEHN, N ;
HATZ, R ;
MANNES, GA ;
OERTEL, H ;
SAUERBRUCH, T ;
STOLTE, M .
GASTROENTEROLOGY, 1992, 102 (05) :1575-1582
[6]  
BAYERDORFFER E, 1992, EUR J GASTROEN HEPAT, V4, P697
[7]   DOUBLE-BLIND TRIAL OF OMEPRAZOLE AND AMOXICILLIN TO CURE HELICOBACTER-PYLORI INFECTION IN PATIENTS WITH DUODENAL-ULCERS [J].
BAYERDORFFER, E ;
MIEHLKE, S ;
MANNES, GA ;
SOMMER, A ;
HOCHTER, W ;
WEINGART, J ;
HELDWEIN, W ;
KLANN, H ;
SIMON, T ;
SCHMITT, W ;
BASTLEIN, E ;
EIMILLER, A ;
HATZ, R ;
LEHN, N ;
DIRSCHEDL, P ;
STOLTE, M .
GASTROENTEROLOGY, 1995, 108 (05) :1412-1417
[8]   TOPOGRAPHIC ASSOCIATION BETWEEN ACTIVE GASTRITIS AND CAMPLYLOBACTER-PYLORI COLONIZATION [J].
BAYERDORFFER, E ;
OERTEL, H ;
LEHN, N ;
KASPER, G ;
MANNES, GA ;
SAUERBRUCH, T ;
STOLTE, M .
JOURNAL OF CLINICAL PATHOLOGY, 1989, 42 (08) :834-839
[9]   SHORT-TERM LOW-DOSE TRIPLE THERAPY FOR THE ERADICATION OF HELICOBACTER-PYLORI [J].
BAZZOLI, F ;
ZAGARI, RM ;
FOSSI, S ;
POZZATO, P ;
ALAMPI, G ;
SIMONI, P ;
SOTTILI, S ;
RODA, A ;
RODA, E .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1994, 6 (09) :773-777
[10]  
BELL GD, 1991, EUR J GASTROEN HEPAT, V3, P923